Opaleye Management Inc.'s Form 4 filing
Grace Therapeutics, Inc. (GRCE) · filed Sep 23, 2026
- Accession no.
- 0001493152-26-043996
- Filed
- Sep 23, 2026, 6:19 PM ET
- Trade date
- Sep 21-23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $31.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +9,771 | $2.10 | +$20,519.1 | 2,850,000 | Indirect | |
| Sep 23, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +5,318 | $2.10 | +$11,167.8 | 2,855,318 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.